Importantly, we also found that nuclear TIAM1 levels were increased in advanced-stage NSCLC human tumors and correlated with poor survival of NSCLC patients, again in contrast to what we have previously observed in colorectal cancer (30). This evidence concerns the gene TIAM1 and colorectal cancer.